Efficacy of osimertinib for lung squamous cell carcinoma with de novo EGFR T790M‐positive: Case report and literature review

Among epidermal growth factor receptor (EGFR) mutation‐positive non‐small cell lung cancers, squamous cell carcinoma is less common and shows lower responsiveness to first‐generation EGFR tyrosine kinase inhibitors (TKIs) compared to adenocarcinoma. However, the efficacy of osimertinib for squamous...

Descripción completa

Detalles Bibliográficos
Autores principales: Maeda, Chihiro, Shinada, Kanako, Murakami, Shuji, Saito, Haruhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2023
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542461/
https://www.ncbi.nlm.nih.gov/pubmed/37641467
http://dx.doi.org/10.1111/1759-7714.15081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542461/
https://www.ncbi.nlm.nih.gov/pubmed/37641467
http://dx.doi.org/10.1111/1759-7714.15081

Ejemplares similares